CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $192,000 | -37.7% | 45,344 | -26.6% | 0.00% | -100.0% |
Q1 2021 | $308,000 | -60.6% | 61,772 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $781,000 | +28.7% | 61,772 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $607,000 | -34.3% | 61,772 | -33.5% | 0.00% | 0.0% |
Q2 2020 | $924,000 | -29.5% | 92,910 | -37.3% | 0.00% | -33.3% |
Q1 2020 | $1,310,000 | -4.1% | 148,166 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $1,366,000 | +56.7% | 148,166 | 0.0% | 0.00% | +50.0% |
Q3 2019 | $872,000 | -65.6% | 148,166 | -29.8% | 0.00% | -60.0% |
Q2 2019 | $2,532,000 | +651.3% | 210,966 | +656.2% | 0.01% | +400.0% |
Q1 2019 | $337,000 | +31.1% | 27,900 | +61.3% | 0.00% | 0.0% |
Q3 2018 | $257,000 | -11.7% | 17,300 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $291,000 | -51.5% | 17,300 | -34.0% | 0.00% | -50.0% |
Q1 2018 | $600,000 | – | 26,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |